<DOC>
	<DOCNO>NCT00086138</DOCNO>
	<brief_summary>The purpose study learn whether treat individual Alzheimer 's disease depression anti-depressant medication sertraline ( Zoloft ) helpful people Alzheimer 's disease family caregiver .</brief_summary>
	<brief_title>Depression Alzheimer 's Disease-2</brief_title>
	<detailed_description>Participants randomly assign treatment sertraline ( range 25-125 mg per day ) identical placebo 24 week . There 8 schedule in-person visit 24 week . Visits include neuropsychological testing . Caregivers ask patient Daily Affect Diary 6 week study period . Telephone followup do week 36 48 . Both group receive caregiver support/education .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Inclusion : Ability participant , caregiver surrogate provide write informed consent . Dementia due Alzheimer 's disease Stable treatment Alzheimer 's disease Ability participant 's caregiver accompany participant study visit participate study . Exclusion Presence brain disease might otherwise explain presence dementia Clinically significant hallucination delusion Current treatment antipsychotic , anticonvulsant , antidepressant , benzodiazepine , psychotropic medication Need hospitalization residence nursing facility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Depression</keyword>
</DOC>